04.17.26 -- All The Ways Global Biopharma Still Grapples With Annex 1

This session highlights common late-stage risks and discusses how a stronger stability design can support confident IND, BLA, and long-term supply strategies.

Stricter regulatory expectations for AAV therapies demand robust control of residual transfection reagents, comprehensive documentation, and proactive quality strategies to avoid delays.

With many blockbuster drug patents set to expire by 2030, the market is ripe for biosimilar developers to stake their claim. To succeed, they must be strategic and compliant.

Uncover how biofluorescent technology with particle concentration capability consolidates viable monitoring, total particle counting, and sample collection into a single Annex 1-compliant platform.

Standardizing quality processes across fourteen sites has enabled faster lead times. Discover how a unified platform reduces complexity, improves compliance, and delivers greater value for customers.

Whether you are new to Organ-on-a-Chip technology or seeking to expand your expertise, watch to gain the knowledge and insights needed to effectively implement this technology into your research.

Biotherapeutic peptides offer enhanced safety and efficacy over traditional drugs. Learn why rigorous impurity profiling is vital to ensure product quality, patient safety, and regulatory compliance.

Modern optical microscopy reveals cellular activity and material quality with exceptional clarity. See how tailored, feature‑rich imaging systems help researchers generate high‑value data.

Find out how a leading genomics facility advances long‑read sequencing through rigorous QC and flexible workflows, offering practical insights for researchers aiming to improve sequencing outcomes.

Examine how unified asset management enhances audit readiness by connecting maintenance, calibration, and quality insights, as well as how integrated workflows reduce compliance risk.

Personnel-related contamination risks demand more than compliance. Gain insight into practical, risk-based considerations for aseptic gowning that support stronger contamination control strategies.

Read about how to implement a validated, broad-spectrum qPCR workflow that covers over 250 species, ensuring both regulatory compliance and accelerated speed-to-market for your clinical-grade products.

Observe how to choose and validate normalization strategies for western blots, avoid common pitfalls, and ensure reproducible results using proteins tailored to your experimental context.

Decoding immune cell interactions reveals critical insights for cancer therapy. Advanced imaging and spectral analysis enable precise identification of synapses, accelerating immuno-oncology research.

Explore eight essential reasons why leading BioPharma companies trust this GxP partner to support compliance and operational success in regulated environments.

Explore evolving cleaning validation strategies in life sciences, from regulatory foundations to digital innovations, and discover how agile, risk-based approaches can enhance compliance and efficiency.

VHP biodecontamination ensures aseptic manufacturing, but BI variability challenges validation. Addressing rogue BIs and regulatory shifts strengthens contamination control and process reliability.

Modern lab equipment is essential to scientific research, but maintaining it is increasingly complex. Review key challenges and strategies to futureproof your maintenance approach.

Reveal an Isothermal Titration Calorimetry tool that is precise for characterizing molecular interactions, which is crucial for drug discovery and lead optimization in pharmaceutical research.

Quality management in healthcare and life sciences is crucial for optimizing patient health. Discover how modern quality management systems optimize patient outcomes and enhance safety.

A miscalculated analytical approach can be costly to develop, perform, and maintain. Many organizations also lack appropriate resources to create optimal testing methods and protocols.

Efficient quality control of therapeutic oligonucleotides is crucial. Uncover advanced methods combining HPLC-UV and mass spectrometry for precise impurity quantification and mass confirmation.

Learn about the process conditions and protocols that were chosen as optimization targets and the resulting improvements to ADC production and purification that assessing these parameters provided.

Here, we provide systematic methods to increase return on investment. Examine the seven primary investment recovery channels.

Gain insight into comprehensive analytics comparing MSC-EV quality attributes across tissue sources, donors, and scalable production platforms to identify critical manufacturing variables.